Abstract:Various vinyl sulfone functionalized dextrans (dex-VS) (M-n,M-dextran = 14K or 31K) with degrees of substitution (DS) ranging from 2 to 22 were conveniently prepared by a one-pot synthesis procedure at room temperature. This procedure involved reaction of a mercaptoalkanoic acid with an excess amount of divinyl sulfone yielding vinyl sulfone alkanoic acid, followed by conjugation to dextran using N,N'-dicyclohexylcarbodiimide (DCC)/4-(dimethylamino)pyridinium 4-toluenesulfonate (DPTS) as a catalyst system. By using two different mercaptoalkanoic acids, 3-mercaptopropionic acid (1a) and 4-mercaptobutyric acid (1b), dex-VS conjugates with either an ethyl spacer (denoted as dex-Et-VS) or a propyl spacer (denoted as dex-Pr-VS) between the thioether and ester groups were obtained. Linear and four-arm mercaptopoly(ethylene glycol) (M-n = 2.1K) with two or four thiol groups (denoted as PEG-2-SH and PEG-4-SH, respectively) were also prepared. Hydrogels were rapidly formed in situ under physiological conditions by Michael type addition upon mixing aqueous solutions of dex-VS and multifunctional PEG-SH at a concentration of 10-20% w/v. The gelation time ranged from 0.5 to 7.5 min, depending on the DS, concentration, dextran molecular weight, and PEG-SH functionality. Rheological studies showed that these dextran hydrogels are highly elastic. The storage modulus increased with increasing DS, concentration, and dextran molecular weight, and hydrogels with a broad range of storage moduli from 3 to 46 kPa were obtained. Swelling/degradation studies revealed that these dextran hydrogels have a low initial swelling and are degradable under physiological conditions. The degradation time varied from 3 to 21 days depending on the DS, concentration, dextran molecular weight, and PEG-SH functionality. Interestingly, dex-Pr-VS hydrogels showed prolonged degradation times, but otherwise similar properties compared to dex-Et-VS hydrogels. The hydrolysis of the linker ester bonds of the dex-VS conjugates under physiological conditions was confirmed by H-1 NMR. The results showed that the hydrolysis kinetics were independent of the DS and the dextran molecular weight. Therefore, the degradation rate of these hydrogels can be precisely controlled.

Sustained zero-order release of dexamethasone after incorporation into crosslinked PEG-dendrons using click reactions

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Biodegradable dexamethasone polymer capsule for long-term release

Assessment of the drug loading, in vitro and in vivo release behavior of novel pH-sensitive hydrogel

Controlled Release of Dexamethasone from Porous PLGA Scaffolds under Cyclic Loading

Dexamethasone release from hyaluronic acid microparticle and proanthocyanidin-gelatin hydrogel in sciatic tissue regeneration

Dual‐Crosslinked Human Serum Albumin‐Polymer Hydrogels for Affinity‐Based Drug Delivery

Biodegradable Hyaluronic Acid Hydrogels to Control Release of Dexamethasone Through Aqueous Diels-Alder Chemistry for Adipose Tissue Engineering

Weak acid-initiated slow release of Dexamethasone from hydrogel to treat orbital inflammation

Thermoresponsive polymeric dexamethasone prodrug for arthritis pain

Dexamethasone Long-Term Controlled Release from Injectable Dual-Network Hydrogels with Porous Microspheres Immunomodulation Promotes Bone Regeneration

Sustained Intravitreal Delivery of Dexamethasone Using an Injectable and Biodegradable Thermogel.

Cross-linked Vegetable Oil with Covalently Loaded Dexamethasone: Linear Drug Release for Osteogenic Induction of Hbmscs in Vitro

Preparation of Dex/PVA composite gel and its controlled release of coenzyme A

Drug release mechanisms of high-drug-load, melt-extruded dexamethasone intravitreal implants

Controllable Dual-Release of Dexamethasone and Bovine Serum Albumin from Plga/Beta-Tricalcium Phosphate Composite Scaffolds

Rapidly in Situ-Forming Degradable Hydrogels from Dextran Thiols Through Michael Addition.

Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells and diagnostic applications

Synthesis, characterization of dextran hydrogels and their in vitro release of gentamycin sulphate.

Novel in Situ Forming, Degradable Dextran Hydrogels by Michael Addition Chemistry: Synthesis, Rheology, and Degradation

Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases